Clinical Trials Logo

Clinical Trial Summary

Patients will be divided into three groups. Group H patients will be given 100 mg Hydroxyzine orally 1 hour before surgery while group A patients will receive 0.5 mg Alprazolam orally. group P will be placebo group. Amsterdam Preoperative Anxiety and Knowledge Scale (APAIS) anxiety scores will be evaluated and recorded 1 hour before surgery. APAIS score will be evaluated again in the the operation room before surgery started. After base measurements of patients are recorded with standard monitoring, spinal block will be performed with 15 mg Heavy Bupivacaine from the L2-L3 or L3-L4 levels of spinal cord in sting position. When T10 level sensory block and Bromage 0-1 neuromusculer block will be occured , surgery will be started. Heart rate, non-invasive arterial blood pressure and the degree of peripheral O2 saturation will be measured at 5 minutes interval throughout the operation. IOWA anesthesia satisfaction scale will also performed to the patients the day after the surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04184141
Study type Interventional
Source Istanbul Medeniyet University
Contact OZGUN TOPCUOGLU, MD
Phone +905318970188
Email ozgntopcuoglu@gmail.com
Status Not yet recruiting
Phase Phase 4
Start date December 1, 2019
Completion date September 1, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05264077 - Sedating Effects of Dexmedetomidine Versus Midazolam in Agitated Patients Undergoing Weaning in Icu. Early Phase 1
Completed NCT05451381 - Vasopressor Requirements Depends on Sedation Strategy N/A
Completed NCT04270331 - Assessment and Management of Pain, Agitation, Delirium and Sleep Deprivation (PADS) in ICU by PADS Protocol, Thailand N/A